HFA-ICOS Baseline Cardio-Oncology Risk Assessment for VEGF Inhibitors

Código: 10644 · hfa_icos_baseline_cardio_oncology_risk_assessment_vegf_inhibitors

Stratifies cardiotoxicity risk in cancer patients scheduled to receive VEGF inhibitor therapy.